One-Pot Multicomponent Synthesis of Pyrazolo[3,4-d]pyrimidine-6-one Derivatives

References

• Chauhan, M. and R. Kumar. “Medicinal attributes of pyrazolo[3,4-d]pyrimidines: A review.” Bioorg. Med. Chem. 21 (2013): 5657–68.
   PubMed Web of Science ®Google Scholar
• Schenone, S., M. Radi, F. Musumeci, C. Brullo, and M. Botta. “Biologically Driven Synthesis of Pyrazolo[3,4-d]pyrimidines As Protein Kinase Inhibitors: An Old Scaffold As a New Tool for Medicinal Chemistry and Chemical Biology Studies.” Chem. Rev. 114 (2014): 7189–238.
   PubMed Web of Science ®Google Scholar
• Marr, J. J. “Purine analogs as chemotherapeutic agents in leishmaniasis and American trypanosomiasis.” J. Lab. Clin. Med. 118 (1991): 111–9.
   PubMed Web of Science ®Google Scholar
• Shamroukh, A. H., A. E. Rashad, R. E. Abdel-Megeid, H. S. Ali, and M. M. Ali. “Some pyrazole and pyrazolo[3,4-d]pyrimidine derivatives: synthesis and anticancer evaluation.” Arch. Pharm. (Weinheim). 347 (2014): 559–65.
   PubMed Web of Science ®Google Scholar
• Abdellatif, K. R., E. K. Abdelall, M. A. Abdelgawad, R. R. Ahmed, and R. B. Bakr. “Synthesis and anticancer activity of some new pyrazolo[3,4-d]pyrimidin-4-one derivatives.” Molecules 19 (2014): 3297–309.
   PubMedGoogle Scholar
• Bakr, R. B., E. K. A. Abdelall, M. K. Abdel-Hamid, and M.M. Kandeel. “Design and Synthesis of New EGFR-tyrosine Kinase Inhibitors Containing Pyrazolo [3,4-d] Pyrimidine Cores as Anticancer Agents.” Bull. Pharm. Sci. Assiut Univ. 35 (2012): 1–16.
   Google Scholar
• Abd El Hamid, M.K., M.D. Mihovilovic, and H.B. El-Nassan. “Synthesis of Novel Pyrazolo[3,4-d]pyrimidine Derivatives as Potential Anti-Breast Cancer Agents.” Eur. J. Med. Chem. 57 (2012): 323–8.
   PubMed Web of Science ®Google Scholar
• Rashad, A. E., A. E. Mahmoud, and M.M. Ali. “Synthesis and Anticancer Effects of Some Novel pyrazolo[3,4-d]pyrimidine Derivatives by Generating Reactive Oxygen Species in Human Breast Adenocarcinoma Cells.” Eur. J. Med. Chem. 46 (2011): 1019–26.
   PubMed Web of Science ®Google Scholar
• Ghorab, M. M., F. A. Ragab, S. I. Alqasoumi, A. M. Alafeefy, and S. A. Aboulmagd. “Synthesis of some new pyrazolo[3,4-d]pyrimidine derivatives of expected anticancer and radioprotective activity.” Eur. J. Med. Chem. 45 (2010): 171–8.
   PubMed Web of Science ®Google Scholar
• Hassan, G. S., H. H. Kadry, S. M. Abou-Seri, M. M. Ali, and A. E. El-Din Mahmoud. “Synthesis and in vitro cytotoxic activity of novel pyrazolo[3,4-d]pyrimidines and related pyrazole hydrazones toward breast adenocarcinoma MCF-7 cell line.” Bioorg. Med. Chem. 19 (2011): 6808–17.
   PubMed Web of Science ®Google Scholar
• Khobragade, C. N., R. G. Bodade, S. G. Konda, B. S. Dawane, and A. V. Manwar. “Synthesis and antimicrobial activity of novel pyrazolo[3,4-d]pyrimidin derivatives.” Eur. J. Med. Chem. 45 (2010) 1635–8.
   PubMedGoogle Scholar
• Gomha, S. M. and H. M. Hassaneen. “Synthesis and antimicrobial Activity of Some New Pyrazoles, Fused Pyrazolo [3,4-d]-pyrimidine and 1, 2-dihydroimidazo-[2,1-c][1,2,4] triazin-6-one derivatives.” Molecules 16 (2011): 6549–60.
   PubMed Web of Science ®Google Scholar
• Bakavoli, M., G. Bagherzadeh, M. Vaseghifar, A. Shiri, M. Pordel, M. Mashreghi, P. Pordeli, and M. Araghi. “Molecular Iodine Promoted synthesis of New Pyrazolo[3,4-D]Pyrimidine Derivatives as Potential Antibacterial Agents.” Eur. J. Med. Chem. 45 (2010): 647–50.
   PubMed Web of Science ®Google Scholar
• El-Sayed Ali, T. “Synthesis of some novel pyrazolo[3,4-b]pyridine and pyrazolo[3,4-d]pyrimidine derivatives bearing 5,6-diphenyl-1,2,4-triazine moiety as potential antimicrobial agents.” Eur. J. Med. Chem. 44 (2009): 4385–92.
   PubMed Web of Science ®Google Scholar
• Rashad, A. E., A. H. Shamroukh, R. E. Abdel-Megeid, A. Mostafa, M. A. Ali, and K. Banert. “A facile synthesis and anti-avian influenza virus (H5N1) screening of some novel pyrazolopyrimidine nucleoside derivatives.” Nucleos. Nucleot. Nucl. 29 (2010): 809–20.
   PubMed Web of Science ®Google Scholar
• Chern, J. H., K. S. Shia, T. A. Hsu, C. L. Tai, C. C. Lee, Y. C. Lee, C. S. Chang, S. N. Tseng, and S.R. Shih. “Design, Synthesis, and structure-activity Relationships of pyrazolo[3,4-d]pyrimidines: a Novel Class of Potent Enterovirus Inhibitors.” Bioorg. Med. Chem. Lett. 14 (2004) 2519–25.
   PubMed Web of Science ®Google Scholar
• Karoui, A., F. Allouche, M. Deghrigue, A. Agrebi, A. Bouraoui, and F. Chabchoub. “Synthesis and Pharmacological Evaluation of Pyrazolopyrimidopyrimidine Derivatives: Anti-inflammatory Agents with Gastroprotective Effect in rats.” Med. Chem. Res. 23 (2014): 1591–8.
   PubMed Web of Science ®Google Scholar
• Yewale, S. B., S. B. Ganorkar, K. G. Baheti, and R. U. Shelke. “Novel 3-substituted-1-aryl-5-phenyl-6-Anilinopyrazolo[3,4-d]pyrimidin-4-ones: Docking, Synthesis and Pharmacological Evaluation As a Potential Anti-Inflammatory Agents.” Bioorg. Med. Chem. Lett. 22 (2012): 6616–20.
   PubMed Web of Science ®Google Scholar
• Antonelli, A., G. Bocci, P. Fallahi, C. La Motta, S.M. Ferrari, C. Mancusi, A. Fioravanti, T. Di Desidero, S. Sartini, A. Corti, S. Piaggi, G. Materazzi, C. Spinelli, G. Fontanini, R. Danesi, F. Da Settimo, and P. Miccoli. “CLM3, a multitarget tyrosine kinase inhibitor with antiangiogenic properties, is active against primary anaplastic thyroid cancer in vitro and in vivo.” J. Clin. Endocrinol. Metab. 99 (2014): E572–81.
   PubMed Web of Science ®Google Scholar
• Devesa, I., M. J. Alcaraz, R. Riguera, and M. L. Ferrándiz. “A New Pyrazolo Pyrimidine Derivative Inhibitor of Cyclooxygenase-2 with Anti-Angiogenic Activity.” Eur. J. Pharmacol. 488 (2004): 225–30.
   PubMed Web of Science ®Google Scholar
• Avasthi, K., N. Garg, T. Chandra, D. S. Bhakuni, P.P. Gupta, and R. C. Srimal. “Synthesis of 4-amino/hydroxy-6-methylthio-12-(2′;, 2′-diethoxyethyl)-1H/2H-pyrazolo [3, 4-d] Pyrimidines and Their Antiallergic Activity.” Eur. J. Med. Chem. 28 (1993): 585–91.
   Web of Science ®Google Scholar
• Gatta, F., L. Gradoni, E. Lupardini, M. Gramiccia, and S. Orsini. “Synthesis and Antileishmanial Activity of some 1- or 2-(dihydroxyalkyl) and 3-(dihydroxyalkoxy)pyrazolo [3,4-d] Pyrimidines.” Farmaco. 46 (1991): 75–84.
   PubMedGoogle Scholar
• Venkatesan, G., P. Paira, S.L. Cheong, S. Federico, K.N. Klotz, G. Spalluto, and G. Pastorin. “A Facile and Novel Synthesis of N2-, C6-Substituted Pyrazolo[3,4-d]pyrimidine-4 Carboxylate Derivatives as Adenosine Receptor Antagonists.” Eur. J. Med. Chem. 92 (2015): 784–98.
   PubMed Web of Science ®Google Scholar
• Venkatesan, G., P. Paira, S. L. Cheong, K. Vamsikrishna, S. Federico, K. N. Klotz, G. Spalluto, and G. Pastorin. “Discovery of Simplified N²-substituted pyrazolo[3,4-d]pyrimidine Derivatives As Novel Adenosine Receptor Antagonists: Efficient Synthetic Approaches, Biological Evaluations and Molecular Docking Studies.” Bioorg. Med. Chem. 22 (2014): 1751–65.
   PubMedGoogle Scholar
• Kandeel, M. M., L. W. Mohamed, M. K. Abd El Hamid, and A. T. NegmEldin. “Design, Synthesis, and Antitumor Evaluation of Novel Pyrazolo [3,4-d] Pyrimidine Derivatives.” Sci. Pharm. 80 (2012): 531–45.
   PubMedGoogle Scholar
• He, H.Y., J. N. Zhao, R. Jia, Y.L. Zhao, S.Y. Yang, L.T. Yu, and L. Yang. “Novel pyrazolo[3,4-d]pyrimidine derivatives as potential antitumor agents: exploratory synthesis, preliminary structure-activity relationships, and in vitro biological evaluation.” Molecules 16 (2011): 10685–94.
   PubMed Web of Science ®Google Scholar
• Nassar, I. F., S. R. Atta-Allah, and A. S. Elgazwy. “A Convenient Synthesis and Molecular Modeling Study of novel pyrazolo[3,4-d]pyrimidine and Pyrazole Derivatives as Anti-tumor agents.” J. Enzyme Inhib. Med. Chem. 30 (2015): 396–405.
   PubMed Web of Science ®Google Scholar
• Hayat, F., A. Salahuddin, and A. Azam. “Synthesis, Characterization, Antiamoebic Activity and Cytotoxicity of New Pyrazolo[3,4-d]pyrimidine-6-one Derivatives.” J. Enzyme Inhib. Med. Chem. 26 (2011): 472–9.
   PubMed Web of Science ®Google Scholar
• Trivedi, A., S. Vaghasiya, B. Dholariya, D. Dodiya, and V. Shah. “Synthesis and Antimycobacterial Evaluation of various 6-substituted Pyrazolo[3,4-d]pyrimidine Derivatives.” J. Enzyme Inhib. Med. Chem. 25 (2010): 893–9.
   PubMed Web of Science ®Google Scholar
• Yadava, U., M. Singh, and M. Roychoudhury. “Pyrazolo[3,4-d]pyrimidines as Inhibitor of Anti-coagulation and Inflammation Activities of Phospholipase A2: Insight from Molecular Docking Studies.” J. Biol. Phys. 39 (2013): 419–38.
   PubMed Web of Science ®Google Scholar
• Tintori, C., A. L. Fallacara, M. Radi, C. Zamperini, E. Dreassi, E. Crespan, G. Maga, S. Schenone, F. Musumeci, C. Brullo, A. Richters, F. Gasparrini, A. Angelucci, C. Festuccia, S. Delle Monache, D. Rauh, and M. Botta. “Combining X-ray Crystallography and Molecular Modeling Toward the Optimization of Pyrazolo[3,4-d]pyrimidines as Potent c-Src inhibitors Active in Vivo Against Neuroblastoma.” J. Med. Chem. 58 (2015): 347–61.
   PubMed Web of Science ®Google Scholar
• Ceccherini, E., P. Indovina, C. Zamperini, E. Dreassi, N. Casini, O. Cutaia, I. M. Forte, F. Pentimalli, L. Esposito, M. S. Polito, S. Schenone, M. Botta, and A. Giordano. “SRC Family Kinase Inhibition Through a New pyrazolo[3,4-d]pyrimidine Derivative as a Feasible Approach for Glioblastoma Treatment.” J. Cell Biochem. 116 (2015): 856–63.
   PubMed Web of Science ®Google Scholar
• Siddiqui, A. B., A. R. Trivedi, V. B. Kataria, and V. H. Shah. “4,5-Dihydro-1H-pyrazolo [3,4-d] Pyrimidine Containing Phenothiazines as Antitubercular Agents.” Bioorg. Med. Chem. Lett. 24 (2014): 1493–5.
   PubMed Web of Science ®Google Scholar
• Le Brazidec, J. Y., A. Pasis, B. Tam, C. Boykin, C. Black, D. Wang, G. Claassen, J. H. Chong, J. Chao, J. Fan, K. Nguyen, L. Silvian, L. Ling, L. Zhang, M. Choi, M. Teng, N. Pathan, S. Zhao, T. Li, and A. Taveras. “Synthesis, SAR and Biological Evaluation of 1,6-disubstituted-1H-pyrazolo[3,4-d]pyrimidines as Dual Inhibitors of Aurora Kinases and CDK1.” Bioorg. Med. Chem. Lett. 22 (2012): 2070–4.
   PubMedGoogle Scholar
• Navarra, M., M. Celano, J. Maiuolo, S. Schenone, M. Botta, A. Angelucci, P. Bramanti, and D. Russo. “Antiproliferative and Pro-apoptotic Effects Afforded by Novel Src-Kinase Inhibitors in Human Neuroblastoma Cells. BMC Cancer 10 (2010): 602.
   PubMed Web of Science ®Google Scholar
• Ferrari, S. M., P. Fallahi, C. La Motta, G. Bocci, A. Corrado, G. Materazzi, D. Galleri, S. Piaggi, R. Danesi, F. Da Settimo, P. Miccoli, and A. Antonelli. “Antineoplastic Activity of the Multitarget Tyrosine Kinase Inhibitors CLM3 and CLM94 in Medullary Thyroid Cancer in vitro.” Surgery. 156 (2014): 1167–76.
   PubMed Web of Science ®Google Scholar
• Jiang, M. X., N. C. Warshakoon, and M. J. Miller. “Chemoenzymatic Asymmetric Total Synthesis of Phosphodiesterase Inhibitors: Preparation of a Polycyclic Pyrazolo[3,4-d]pyrimidine from an Acylnitroso Diels-Alder Cycloadduct-derived Aminocyclopentenol.” J. Org. Chem. 70 (2005): 2824–7.
   PubMed Web of Science ®Google Scholar
• Hutson, P. H., E. N. Finger, B. C. Magliaro, S. M. Smith, A. Converso, P. E. Sanderson, D. Mullins, L. A. Hyde, B. K. Eschle, Z. Turnbull, H. Sloan, M. Guzzi, X. Zhang, A. Wang, D. Rindgen, R. Mazzola, J. A. Vivian, D. Eddins, J. M. Uslaner, R. Bednar, C. Gambone, W. Le-Mair, M.J. Marino, N. Sachs, G. Xu, and S. Parmentier-Batteur. “The Selective Phosphodiesterase 9 (PDE9) Inhibitor PF-04447943 (6-[(3S,4S)-4-methyl-1-(pyrimidin-2-ylmethyl)pyrrolidin-3-yl]-1-(tetrahydro-2H-pyran-4-yl)-1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one) Enhances Synaptic Plasticity and Cognitive Function in Rodents.” Neuropharmacology 61 (2011): 665–76.
   PubMed Web of Science ®Google Scholar
• Xia, Y., S. Chackalamannil, M. Czarniecki, H. Tsai, H. Vaccaro, R. Cleven, J. Cook, A. Fawzi, R. Watkins, and H. Zhang. “Synthesis and Evaluation of Polycyclic Pyrazolo[3,4-d]pyrimidines as PDE1 and PDE5 cGMP Phosphodiesterase Inhibitors.” J. Med. Chem. 40 (1997): 4372–7.
   PubMed Web of Science ®Google Scholar
• Liu, H., H. Q. Wang, and Z. J. Liu. “Synthesis and Herbicidal Activity of Novel Pyrazolo[3,4-d]pyrimidin-4-one Derivatives Containing Aryloxyphenoxypropionate Moieties.” Bioorg. Med. Chem. Lett. 17 (2007): 2203–9.
   PubMed Web of Science ®Google Scholar
• Thummar, B. B., U. P. Tarpada, and D.K. Raval. “Study on One-pot Biginelli-like Synthesis of Pyrazolo[3,4-d]pyrimidines in Brönsted Acidic Ionic Liquid under Sonication and its Mechanism.” J. Hetercyclic Chem. 51 (2014): 1740–6.
   Web of Science ®Google Scholar
• Quiroga, J., J. Trilleras, B. Insuasty, R. Abonía, M. Noguerasb, A. Marchal, and J. Cobo. “Microwave-assisted Synthesis of Pyrazolo[3,4-d]pyrimidines from 2-amino-4,6-dichloropyrimidine-5-carbaldehyde under Solvent-free Conditions.” Tetrahedron Lett. 49 (2008): 3257–9.
   Web of Science ®Google Scholar
• Gu, Y. and F. Jérôme. “Glycerol as a sustainable solvent for green chemistry.” Green Chem. 12 (2010): 1127–38.
   Web of Science ®Google Scholar
• Khaligh, N. G. and F. Shirini. “Preparation, Characterization and use of poly(4-vinylpyridinium) Hydrogen Sulfate Salt as an Eco-benign, Efficient and Reusable Solid Acid Catalyst for the Chemoselective 1,1-diacetate protection and Deprotection of aldehydes.” J. Mol. Catal. A: Chem. 348 (2011): 20–9.
   Web of Science ®Google Scholar